| 24/213 |
Substance Misuse Services & Take-Home Naloxone |
| 24/211 |
LLP, Wholly-Owned Subsidiary, PFI |
| 24/209 |
Processing Freedom of Information Requests |
| 24/208 |
Physician Associates & Anaesthesia Associates 2022 - 2024 |
| 24/207 |
Number of Healthcare Assistants |
| 24/206 |
Data Warehouse & Healthcare Data Exchange Methods |
| 24/205 |
Cancer Diagnosis Errors, Failures or Delays Leading to Fatalities |
| 24/204 |
Safety Incidents Relating to Release of Test Results |
| 24/203 |
Incidence & Treatment of Colorectal Cancer |
| 24/202 |
Spend on Bank and Agency Doctors & Nurses |
| 24/201 |
Patient Deaths in 2023 Awaiting Planned Care |
| 24/200 |
Use of Multifunctional Devices & Managed Print Services |
| 24/198 |
Treatment for Myelofibrosis |
| 24/197 |
Radiology Information System (RIS) Software |
| 24/195 |
Gynaecology, Urology & General Surgery |
| 24/194 |
A&E Attendances |
| 24/193 |
Complex Home Care Packages |
| 24/192 |
Technology |
| 24/190 |
Disciplinary Process |
| 24/189 |
Undergraduate Medical Education Funding |
